US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist
  • 164.660
  • +0.410+0.25%
Close Apr 18 16:00 ET
  • 164.990
  • +0.330+0.20%
Post 17:59 ET
291.55BMarket Cap60.54P/E (TTM)

About AbbVie Company

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Company Profile

SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
Founded2011
CEOMr. Richard A. Gonzalez
MarketNYSE
Employees50000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900

Company Executives

  • Name
  • Position
  • Salary
  • Richard A. Gonzalez
  • Chairman of the Board and Chief Executive Officer
  • 25.66M
  • Jeffrey Ryan Stewart
  • Executive Vice President and Chief Commercial Officer
  • 15.35M
  • Dr. Roopal Thakkar, M.D.
  • Senior Vice President and Chief Medical Officer, Global Therapeutics
  • --
  • Dr. Thomas J. Hudson, M.D.
  • Senior Vice President and Chief Scientific Officer, Global Research
  • --
  • Dr. Nicholas Donoghoe
  • Executive Vice President, Chief Business and Strategy Officer
  • --
  • Timothy J. Richmond
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Robert A. Michael
  • President and Chief Operating Officer
  • 14.44M
  • Scott Reents
  • Executive Vice President and Chief Financial Officer
  • 10.19M
  • Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
  • Executive Vice President and Chief Operations Officer
  • 9.30M
  • Kevin K. Buckbee
  • Senior Vice President, Controller and Principal Accounting Officer
  • --
  • Perry C. Siatis
  • Executive Vice President, General Counsel and Secretary
  • --
  • Edward J. Rapp
  • Independent Director
  • 394.98K
  • Thomas C. Freyman
  • Independent Director
  • 389.98K
  • Rebecca B. Roberts
  • Independent Director
  • 359.98K
  • Melody B. Meyer
  • Independent Director
  • 369.98K
  • Dr. Robert J. Alpern,M.D.
  • Independent Director
  • 461.18K
  • Roxanne S. Austin
  • Independent Director
  • 388.39K
  • Jennifer L. Davis
  • Independent Director
  • 45.00K
  • Brett J. Hart
  • Independent Director
  • 384.98K
  • William H.L. Burnside
  • Independent Director
  • 377.48K
  • Frederick H. Waddell
  • Independent Director
  • 369.98K
  • Dr. Susan E. Quaggin, M.D.
  • Independent Director
  • 24.00K
  • Glenn F. Tilton
  • Lead Independent Director
  • 421.58K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg